Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-057918
Filing Date
2014-09-15
Accepted
2014-09-15 16:48:07
Documents
1
Period of Report
2014-09-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3996
  Complete submission text file 0001209191-14-057918.txt   5393
Mailing Address C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE MA 02109
Business Address
Renaud Ronald C JR (Reporting) CIK: 0001354434 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36352 | Film No.: 141103650

Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Issuer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations